Cystic fibrosis: nutritional consequences and management
John A Dodge1, Dominique Turck
1Singleton Hospital, University of Wales Swansea, Swansea SA2 8QA, UK. j.a.dodge@btinternet.com
Best Practice & Research. Clinical Gastroenterology
|June 20, 2006
Summary
Optimizing nutrition is key for improving Cystic Fibrosis (CF) patient outcomes. Expert dietetic care ensures adequate energy and nutrient intake, crucial for managing CF complications and enhancing survival.
Area of Science:
- Medical Science
- Nutritional Science
- Pulmonology
Background:
- Life expectancy for Cystic Fibrosis (CF) patients has significantly increased, with childhood mortality now rare.
- Nutritional status is intrinsically linked to pulmonary health and survival in CF patients.
- Increased metabolic demands in CF arise from malabsorption, chronic infections, and impaired lung function.
Purpose of the Study:
- To highlight the critical role of nutrition in Cystic Fibrosis (CF) management.
- To underscore the necessity of expert dietetic care for CF patients.
- To discuss the challenges and strategies in optimizing nutritional status for improved patient outcomes.
Main Methods:
- Review of current nutritional management strategies for Cystic Fibrosis (CF).
- Analysis of the impact of CF complications on nutritional requirements.
- Discussion of therapeutic interventions including Pancreatic Enzyme Replacement Therapy (PERT) and nutritional supplements.
Main Results:
- Pancreatic enzyme replacement therapy (PERT) is essential for a majority of CF patients, with prevalence varying geographically.
- CF patients frequently experience deficiencies in fat-soluble vitamins, essential fatty acids, and minerals.
- CF-related diabetes and osteopenia are common complications requiring specific management approaches.
Conclusions:
- Proactive and vigorous management of nutritional challenges is vital for CF patient care.
- Individualized adjustments of Pancreatic Enzyme Replacement Therapy (PERT) and nutritional supplements are standard practice.
- Optimizing nutrition is integral to improving the quality of life and prognosis for individuals with Cystic Fibrosis (CF).
Related Concept Videos
Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

